Drugs / CKD-825
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03950843 | Apr 2019 → Sep 2021 | atrial fibrillation | Chong Kun Dang Pharmaceutical | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CKD-825 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03950843 ↗ |